OSTX
OS Therapies (OSTX)
$54
About OS Therapies (OSTX)
OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Grasonville, MD.
Details
Daily high
$1.65
Daily low
$1.54
Price at open
$1.63
52 Week High
$7.00
52 Week Low
$1.12
Market cap
57.0M
Dividend yield
0.00%
Volume
412,923
Avg. volume
404,966
P/E ratio
-1.98
OS Therapies News
Details
Daily high
$1.65
Daily low
$1.54
Price at open
$1.63
52 Week High
$7.00
52 Week Low
$1.12
Market cap
57.0M
Dividend yield
0.00%
Volume
412,923
Avg. volume
404,966
P/E ratio
-1.98